The Woman Who Followed Every Protocol and Still Got Worse
Sandra was 34 when her immune system declared war on her thyroid. The diagnosis: Hashimoto’s thyroiditis, her body producing antibodies against its own thyroid tissue. She did everything right — went gluten-free, cut dairy, bought the supplements her naturopath recommended, followed the autoimmune protocol diet from a popular book. Her TPO antibodies dropped modestly at first. Then she got shingles at 35, a condition typically seen in people over 60 or those with severely compromised immune systems. Then a rash showed up on her arms that her dermatologist called psoriasis. Then food sensitivities kept expanding, seemingly at random, until eating had become a source of anxiety rather than sustenance. She was following every protocol, spending hundreds of dollars a month on supplements, and getting progressively worse.
What Sandra’s various practitioners had been treating were symptoms. Nobody had looked at the system connecting all of them: her gut. More specifically, nobody had explained that her gut wall had become abnormally permeable — that this permeability was continuously feeding the immune dysregulation driving her conditions — and that without addressing this root physiological problem, dietary manipulation alone would produce limited and temporary improvements at best.
Sandra had intestinal hyperpermeability. What the wellness world calls “leaky gut.” And this permeability was the pivot her entire autoimmune trajectory was turning on. This article is about the connection between intestinal permeability and autoimmunity: why it matters mechanistically, and what the evidence actually reveals.
The Gut Barrier: Biology You Need to Understand
The gastrointestinal tract is the largest interface between the human body and the outside world. The total surface area of the intestinal lining, if unfolded completely, would cover approximately 400 square meters — roughly the size of a tennis court. Every day this enormous surface has to accomplish two apparently contradictory tasks at once: allow nutrients, water, and beneficial compounds into the bloodstream while simultaneously keeping out bacteria, bacterial toxins, incompletely digested food proteins, and metabolic waste.
The primary mechanism for this selective permeability is the epithelial cell monolayer — a single cell-thick lining of the intestine — connected to neighboring cells by protein structures called tight junctions. These are not static seals. They dynamically open and close in response to physiological signals, regulating how much space exists between epithelial cells and therefore what can pass through the paracellular (between-cell) route into the bloodstream. Key tight junction proteins include occludin, claudins, and zona occludens proteins (ZO-1, ZO-2) — and each can be disrupted by specific dietary, microbial, and environmental factors.
When tight junctions function correctly, the gut barrier is extraordinarily selective. Large molecules — proteins, bacteria, bacterial cell wall fragments — get blocked from paracellular passage. Nutrients pass through transcellular routes subject to specific receptor-mediated transport. The immune system keeps constant surveillance but doesn’t face the flood of foreign material it would if permeability increased.
When tight junctions are disrupted — by certain dietary proteins, chronic stress, gut infections, antibiotic overuse, alcohol, or inflammatory cytokines — the paracellular space widens measurably. Bacterial fragments, undigested food proteins, and lipopolysaccharides (LPS, the endotoxin from gram-negative bacterial cell walls) enter the bloodstream. The immune system — which positions roughly 70-80% of immune cells in gut-associated lymphoid tissue (GALT), precisely because the gut is where most foreign material shows up — detects these molecular invaders and launches an inflammatory response.
This is leaky gut at the mechanistic level. Not vague “toxins in your blood” as much wellness marketing describes it, but specifically the disruption of tight junction proteins allowing inappropriate translocation of immunogenic molecules into systemic circulation, driving chronic immune activation. When this process becomes chronic — when the inflammatory response to translocated material never lets up — the immune system can start making targeting errors, producing antibodies that cross-react with the body’s own tissues. This is the gut-autoimmunity connection in its most direct form.
The Fasano Triad: Understanding Why Autoimmune Disease Develops
Dr. Alessio Fasano, a gastroenterologist and researcher at Massachusetts General Hospital, has produced some of the most mechanistically important research on the gut-autoimmunity connection. His 2012 paper in Clinical Reviews in Allergy & Immunology proposed a model — since widely cited and built upon — that has become central to functional medicine’s understanding of autoimmune disease initiation: the Fasano Triad.
Factor 1 — Genetic Susceptibility: Certain gene variants — particularly HLA (human leukocyte antigen) genes governing immune recognition — create susceptibility to specific autoimmune conditions. For celiac disease, HLA-DQ2 and HLA-DQ8 variants show up in virtually all cases. For Hashimoto’s thyroiditis, HLA-DR3 and CTLA-4 polymorphisms confer susceptibility. For rheumatoid arthritis, HLA-DRB1 variants carry elevated risk. Genetic susceptibility is necessary but not sufficient — enormous numbers of people carry these variants without ever developing autoimmune disease. Genes load the gun. Something else pulls the trigger.
Factor 2 — Environmental Trigger: Some environmental exposure initiates and perpetuates the autoimmune process. Could be a specific food antigen (gliadin in celiac disease and Hashimoto’s), a pathogen (Epstein-Barr virus has been specifically linked to multiple autoimmune conditions including lupus and multiple sclerosis), toxin exposure (heavy metals, certain agricultural chemicals), or chronic psychological stress. Environmental triggers activate the genetic susceptibility. They turn the potential into the clinical problem.
Factor 3 — Intestinal Hyperpermeability: The environmental trigger can only drive systemic autoimmunity if it can cross the gut barrier in sufficient quantity to stimulate a systemic immune response. Intestinal hyperpermeability is the mechanism through which this crossing happens. Without increased permeability, environmental triggers stay largely contained within the gut lumen and can’t mount the systemic immune challenge autoimmune disease initiation requires. The gut barrier is the gatekeeper.
The profound clinical implication of this model: if intestinal permeability is the necessary gateway through which autoimmune disease initiates and perpetuates, then restoring gut barrier integrity isn’t an alternative intervention — it’s a mechanistically rational treatment addressing one of the three required factors in the disease triad. Genes can’t be changed. Environmental triggers can sometimes be identified and removed. And gut barrier function can be worked on systematically. For a lot of people with autoimmune conditions, this third factor is the most modifiable one, and the most neglected.
The Research: Leaky Gut Across Autoimmune Conditions
The research connecting intestinal hyperpermeability to autoimmune conditions has expanded dramatically over the past two decades. The evidence hierarchy ranges from strongly established (celiac disease) to compelling and growing (Hashimoto’s, type 1 diabetes, rheumatoid arthritis, lupus, multiple sclerosis) to preliminary but mechanistically plausible (many other inflammatory conditions).
Celiac Disease: Fasano’s research group demonstrated that zonulin — a protein secreted by intestinal epithelial cells in response to gliadin and certain bacteria — is the primary physiological regulator of tight junction opening, and that it’s pathologically elevated in celiac patients. Elevated zonulin directly mediates the gut permeability that allows gliadin proteins to cross into systemic circulation and trigger the autoimmune response targeting intestinal villi. This is the most mechanistically complete picture of gut-mediated autoimmunity available, and it serves as the reference model for other conditions (Fasano, 2011, Physiological Reviews).
Type 1 Diabetes: Perhaps the most striking evidence for gut permeability preceding autoimmunity comes from type 1 diabetes research. Kuitunen et al. (2002) in the Journal of Pediatrics documented increased intestinal permeability in first-degree relatives of type 1 diabetes patients who hadn’t yet developed the disease — suggesting hyperpermeability may precede and contribute to autoimmune beta cell destruction rather than simply resulting from it. This prospective evidence for leaky gut as a precursor rather than a consequence of autoimmunity is mechanistically significant.
Rheumatoid Arthritis: RA patients consistently show elevated serum markers of intestinal permeability — increased I-FABP (intestinal fatty acid binding protein, released by damaged enterocytes) and elevated zonulin — compared to healthy controls (Martinez-Moreno et al., 2019). Gut dysbiosis with specific bacterial species (Prevotella copri has drawn particular research attention) appears to drive the gut inflammation feeding RA pathology, and microbiome restoration approaches are beginning to show clinical benefit in RA management.
Multiple Sclerosis: MS patients demonstrate altered gut microbiome composition, increased intestinal permeability markers, and evidence of bacterial translocation into systemic circulation (Camara-Lemarroy et al., 2018, Frontiers in Neurology). The gut-brain axis — the bidirectional communication network between gut microbiome, enteric nervous system, vagus nerve, and central nervous system — may be the pathway through which gut dysbiosis influences neuroinflammation and MS activity. Specific bacterial metabolites (particularly SCFAs) appear to have direct effects on oligodendrocyte function and myelin integrity.
What Damages the Gut Barrier: The Modern Assault
Understanding what disrupts tight junction integrity matters for designing an intervention that actually addresses root causes rather than symptoms. The list of gut barrier disruptors is long, and the modern Western lifestyle reliably delivers multiple hits at once — which may explain why autoimmune disease prevalence has increased 3-5 fold since the mid-20th century in industrialized nations (Lerner et al., 2015, Journal of Autoimmunity).
Gliadin (from gluten-containing grains): Beyond the direct autoimmune trigger in celiac disease, gliadin has been shown to stimulate zonulin release in all humans — not just those with celiac disease or genetic susceptibility — causing measurable, temporary tight junction opening after ingestion. Drago et al. (2006) in the Scandinavian Journal of Gastroenterology demonstrated this effect in intestinal cell cultures from both celiac and non-celiac individuals. The degree of tight junction opening is greater in genetically susceptible individuals but isn’t exclusive to them.
NSAIDs (Ibuprofen, Aspirin, Naproxen): Non-steroidal anti-inflammatory drugs are among the most commonly consumed pharmaceuticals on earth, and they directly disrupt intestinal tight junctions through prostaglandin suppression. Prostaglandins play a critical role in maintaining the intestinal mucus layer and tight junction protein integrity — their suppression by NSAIDs impairs both. Bjarnason et al. (1993) in Gastroenterology documented significant small intestinal permeability increases with regular NSAID use, and chronic NSAID use has been epidemiologically linked to inflammatory bowel disease exacerbation and increased autoimmune risk.
Chronic Psychological Stress: The stress-gut permeability connection operates through multiple neurohormonal pathways. Cortisol and corticotropin-releasing hormone (CRH) directly activate mast cells in the intestinal wall, triggering degranulation and tight junction disruption. Chronic stress reduces secretory IgA (the mucosal immune antibody preventing bacterial adhesion to the epithelium), reduces mucus layer thickness, and alters gut motility in ways that promote dysbiosis. Santos et al. (2001) in the American Journal of Physiology documented that psychological stress increased intestinal permeability in animal models through mast cell-mediated mechanisms, with subsequent human studies confirming stress-induced permeability increases in IBS patients with inflammatory presentations.
Alcohol: Ethanol and its primary metabolite acetaldehyde are directly toxic to intestinal epithelial cells. Alcohol disrupts tight junction proteins — specifically occludin and claudin-3 — within hours of consumption and increases LPS translocation from gut lumen to circulation even at moderate doses. This alcohol-induced endotoxemia (elevated circulating LPS) is a documented driver of systemic inflammation and has been mechanistically linked to alcohol-associated autoimmune exacerbation.
Dietary Emulsifiers: Emulsifiers widely used in processed foods — carboxymethylcellulose (CMC), polysorbate 80 (P80), carrageenan — are designed to maintain food texture and shelf stability. Research by Chassaing et al. (2015) in Nature found that dietary emulsifiers, at doses achievable through normal processed food consumption, disrupted the gut mucus layer, promoted bacterial penetration toward the epithelium, induced low-grade chronic inflammation, and drove features of metabolic syndrome in animal models. Implication: the emulsifier load of a Western processed food diet may be directly contributing to gut barrier degradation at the population level.
Proton Pump Inhibitors (PPIs): Acid-suppressing medications (omeprazole, lansoprazole, and related drugs) dramatically alter gut microbiome composition by reducing stomach acid, which normally serves as a barrier to microbial colonization. The microbiome changes induced by PPI use include reduced beneficial Lactobacillus and Bifidobacterium species, increased pathobiont colonization, and reduced SCFA production — all of which impair tight junction integrity over time. Long-term PPI use is associated with increased risk of gut infections (Clostridium difficile), SIBO, and emerging evidence links chronic PPI use to increased autoimmune risk.
The Autoimmune Gut Assessment: Framework
The Autoimmune Gut Assessment is a structured framework for systematically evaluating the gut’s potential contribution to autoimmune and inflammatory conditions, and prioritizing interventions based on evidence strength and clinical significance. It’s not a replacement for appropriate medical management — it’s a complementary framework for addressing the gut-mediated drivers that standard autoimmune treatment typically ignores.
- Step 1 — Symptom Pattern Recognition: Assess symptoms across multiple systems suggesting immune dysregulation and gut barrier compromise. GI symptoms: bloating, gas especially after specific foods, alternating constipation and diarrhea, undigested food in stool, multiple food sensitivities that have expanded over time, nausea without clear cause. Systemic: fatigue disproportionate to activity or sleep, brain fog (cognitive impairment after eating certain foods), joint pain without injury history, skin manifestations (eczema, psoriasis, rosacea, hives), recurrent infections suggesting reduced immune resilience. Expanding food sensitivity lists are a particularly telling sign — the gut barrier normally prevents food protein exposure from driving sensitization; when the barrier is compromised, new sensitivities keep developing.
- Step 2 — Objective Permeability Assessment: Functional medicine practitioners order: serum zonulin (elevated suggests increased permeability; note commercial zonulin tests have variable reliability depending on antibody used), serum lipopolysaccharide binding protein (LBP — elevated indicates systemic endotoxin exposure), lactulose/mannitol urine test (gold standard quantification of paracellular permeability), and calprotectin stool test (elevated indicates intestinal inflammation). These provide objective evidence of barrier compromise.
- Step 3 — Microbiome Assessment: Comprehensive stool analysis (GI-MAP, Viome, or Genova GI Effects) assesses pathogen presence, dysbiosis patterns, bacterial diversity, parasitic colonization, and SCFA production capacity. Key findings: H. pylori presence, SIBO risk indicators, Akkermansia muciniphila levels (low = compromised mucus barrier), secretory IgA levels (low = mucosal immune deficiency), and anti-inflammatory SCFA producers (Faecalibacterium prausnitzii, Roseburia).
- Step 4 — Trigger Identification and Elimination: Systematic removal of the most potent gut disruptors: gluten trial elimination (minimum 60-90 days for meaningful clinical assessment — shorter trials are insufficient for autoimmune conditions where the inflammatory response may take months to quiet); dietary emulsifiers and highly processed foods; alcohol reduction or elimination during the restoration phase; NSAID reduction where medically feasible. Environmental toxin assessment if occupational or residential exposure is suspected.
- Step 5 — The 5R Restoration Protocol: The functional medicine 5R framework provides a structured sequence: Remove (disruptors, pathogens, dysbiotic bacteria), Replace (digestive enzymes and HCl if hypochlorhydria is present), Reinoculate (probiotic strains with evidence for tight junction support: L. rhamnosus GG, L. plantarum, B. longum; and prebiotic substrates that feed beneficial bacteria: inulin, FOS, resistant starch), Repair (gut lining targeted nutrients: L-glutamine, zinc carnosine, collagen, butyrate), Rebalance (stress, sleep, circadian biology — the lifestyle factors that determine whether all the other interventions hold).
Key Nutrients for Gut Barrier Repair: What the Research Shows
Several specific nutrients and compounds have meaningful clinical evidence for directly supporting gut barrier integrity and tight junction function. These aren’t generic wellness supplements — they’re compounds with specific mechanistic evidence for reducing intestinal hyperpermeability and supporting epithelial repair.
Zinc Carnosine: This specific chelated form of zinc has the strongest evidence for direct tight junction protein support among zinc forms. Research by Ohkawara et al. (2009) in the Journal of Pharmacology and Experimental Therapeutics found zinc carnosine supplementation significantly reduced intestinal permeability markers and protected occludin and ZO-1 tight junction proteins from damage-induced disruption. Zinc is also a cofactor for hundreds of enzymatic reactions including those driving intestinal epithelial repair and renewal. Standard supplementation dose: 75mg zinc carnosine (roughly 17mg elemental zinc) twice daily.
Butyrate: The primary short-chain fatty acid fuel of colonocytes, butyrate also serves as a direct transcriptional signal for tight junction protein upregulation through histone deacetylase (HDAC) inhibition — a mechanism that directly increases claudin-1 expression and tight junction integrity. Normally produced by gut bacteria fermenting dietary fiber, butyrate production is impaired in dysbiotic states. Increasing prebiotic fiber (resistant starch, inulin, pectin) supports endogenous production. Supplemental sodium butyrate or tributyrin provides direct supply when microbiome production is compromised.
Collagen-Derived Amino Acids (Glycine, Proline): These conditionally essential amino acids — abundant in collagen, gelatin, and bone broth — matter for intestinal epithelial integrity. Glycine has direct anti-inflammatory effects on intestinal macrophages and supports mucus gel layer production. Research suggests these amino acids support tight junction protein synthesis and reduce inflammatory signaling in the gut mucosa. Practical dietary sources: bone broth, hydrolyzed collagen powder, gelatin-containing foods.
Akkermansia muciniphila Support: This specific gut bacterium lives in the intestinal mucus layer and produces enzymes that maintain mucus turnover and thickness — directly supporting the physical barrier between luminal content and the epithelium. Research by Plovier et al. (2017) in Nature Medicine identified Amuc_1100, an outer membrane protein from Akkermansia, as a specific signal for gut barrier function improvement — showing it improved intestinal permeability, reduced endotoxemia, and improved metabolic markers in obese mice. Polyphenol-rich foods — berries, pomegranate, cranberry, red wine in moderation — specifically support Akkermansia colonization and may be the most accessible way to naturally restore this important commensal.
The Gut-Skin Axis: Autoimmunity at the Surface
One of the most striking practical demonstrations of gut permeability’s reach is the gut-skin connection. The skin is the body’s largest organ and one of the most visible manifestations of internal immune dysregulation. Conditions like psoriasis, eczema, rosacea, and acne aren’t primarily skin diseases — they’re immune diseases that manifest at the skin surface, and gut permeability is increasingly recognized as a central driver.
Research by Bowe and Logan (2011) in Gut Pathogens outlined the gut-skin axis in detail, documenting how gut dysbiosis and intestinal hyperpermeability drive the systemic inflammation and immune activation that manifests in skin conditions. Bacterial endotoxins (LPS) crossing a permeable gut barrier bind toll-like receptor 4 (TLR4) on keratinocytes and dermal immune cells, triggering the NFkB inflammatory cascade that produces the clinical features of psoriasis, eczema, and seborrheic dermatitis. Psoriasis patients show significantly elevated serum LPS levels compared to controls — direct evidence of gut-to-circulation bacterial endotoxin translocation driving skin inflammation.
For acne vulgaris, the gut connection operates through multiple pathways: elevated circulating LPS directly stimulates sebaceous gland activity, increases sebum production, and promotes the P. acnes bacterial environment. Dysbiosis-driven systemic inflammation increases androgen sensitivity in sebaceous glands, amplifying acne pathology. Research by Stokes and Pillsbury as far back as 1930 — and dramatically updated with modern microbiome research — supports the gut-skin connection for acne as one of the oldest and most consistently documented associations in dermatology.
For patients with chronic skin conditions who’ve tried topical treatments without sustained success, the gut-first approach may be the therapeutic reframe that changes everything. Addressing gut dysbiosis, restoring barrier integrity, and reducing LPS translocation attacks the mechanism driving the skin inflammation, not merely the downstream manifestation. The most dramatic skin clearing outcomes in functional medicine practice frequently occur not through dermatological intervention but through gut restoration in patients whose skin condition was driven by the gut-skin axis.
Stress, Cortisol, and the Self-Reinforcing Gut-Immune Loop
The stress-gut-immune connection creates one of the most clinically important and least-recognized self-reinforcing cycles in autoimmune disease: chronic stress increases gut permeability → increased permeability drives LPS translocation → systemic LPS elevates circulating cytokines → elevated cytokines increase hypothalamic-pituitary-adrenal (HPA) activation and cortisol → elevated cortisol further increases gut permeability. The loop closes, self-amplifies, and stays invisible to practitioners focused on only one piece of it.
The mechanistic evidence for stress-induced gut permeability is strong. Cortisol and CRH directly activate intestinal mast cells, triggering degranulation and release of proteases that cleave tight junction proteins. Chronic stress reduces secretory IgA — the mucosal immune antibody preventing bacterial attachment to the epithelium, the gut’s first line of specific immune defense. Stress also alters gut motility, slowing transit time in ways that promote dysbiosis and SIBO development, both of which further compromise barrier integrity.
Research by Ghia et al. (2008) in the Journal of Physiology demonstrated that stress-induced gut hyperpermeability was mediated by CRH receptors and was reversible with pharmacological stress management — proving the gut permeability changes aren’t permanent structural damage but dynamically regulated physiological states responsive to stress reduction.
For patients with autoimmune conditions who are also dealing with significant chronic psychological stress, treating the gut while leaving stress physiology unaddressed produces incomplete and often temporary results. The gut keeps getting disrupted by the ongoing cortisol-CRH cycle no matter how carefully the dietary and supplementation protocol is followed. Stress management — sleep optimization, vagal nerve activation through breathing and cold exposure, relationship and work stress reduction — isn’t a soft add-on to the gut healing protocol. It’s mechanistically essential to it.
Leaky Gut Autoimmunity: Your Questions Answered
Q: Is “leaky gut” a real diagnosis or wellness marketing?
A: Intestinal hyperpermeability is a real, measurable physiological phenomenon with extensive peer-reviewed research. The lactulose/mannitol urine test, serum zonulin measurement, and electron microscopy of tight junction proteins all quantify gut barrier compromise objectively. The informal term “leaky gut” is colloquial, but the condition it describes is real and increasingly recognized in mainstream gastroenterology and immunology. The more legitimate debate is about the breadth of conditions causally linked to it — the evidence is strongest for autoimmune and inflammatory conditions and more preliminary for some other claimed associations.
Q: Can the gut barrier actually be restored after it’s been damaged?
A: Yes, substantially. The intestinal epithelium has one of the highest cell turnover rates in the body — the entire lining renews every 3-5 days. That rapid renewal means that with appropriate intervention (removing disruptors, providing key repair nutrients, restoring microbiome diversity), meaningful gut barrier restoration is achievable within weeks to months. Celiac disease patients who strictly eliminate gluten typically show normalization of intestinal permeability within 1-2 years. Other conditions show variable timelines depending on chronicity of damage and completeness of intervention.
Q: Should everyone with an autoimmune condition remove gluten?
A: The evidence most strongly supports strict gluten elimination for celiac disease (medically essential) and Hashimoto’s thyroiditis patients with detectable anti-gliadin antibodies or co-occurring celiac (clinically meaningful antibody reduction documented). For other autoimmune conditions, the Fasano model provides mechanistic rationale and the clinical literature contains compelling case reports and preliminary trials, but large RCT confirmation is lacking. A structured 60-90 day elimination trial is low-risk and provides personal clinical data regardless of theoretical arguments. If meaningful improvement occurs, that’s the answer — regardless of negative celiac testing.
Q: What tests should I request if I suspect gut permeability is driving my autoimmune condition?
A: Standard gastroenterology rarely tests for intestinal permeability. Functional medicine practitioners can order: serum zonulin (elevated = possible increased permeability), serum LBP (elevated = endotoxin translocation), lactulose/mannitol urine test (gold standard permeability quantification), comprehensive stool analysis (GI-MAP or equivalent — microbiome, pathogens, calprotectin, secretory IgA), and serum inflammatory markers (hs-CRP, IL-6, TNF-alpha). Combine these with standard autoimmune antibody panels for a comprehensive picture.
Q: How long to see improvement in autoimmune markers after a gut protocol?
A: Timeline varies significantly. GI symptoms and energy often improve within 4-8 weeks of removing major disruptors. Skin conditions typically show meaningful improvement within 8-16 weeks of gut-directed intervention. Autoimmune antibody levels (TPO, ANA, anti-CCP) generally require 3-12 months of consistent intervention to show meaningful reductions. Clinical disease activity often improves before antibody levels fully normalize. Patience is genuinely necessary here — this is biological remodeling, not symptom suppression.
Q: Is bone broth genuinely useful for gut healing?
A: Bone broth contains meaningful concentrations of glycine, proline, hydroxyproline, and gelatin — amino acids with evidence for supporting intestinal epithelial integrity and mucus layer function. It’s not a miracle cure, and “bone broth heals leaky gut” as a standalone claim overstates the evidence. It is, however, a legitimate and sensible dietary addition to a gut restoration protocol — a food providing conditionally essential amino acids for gut repair at minimal cost and essentially zero risk. It supplements the more potent interventions (microbiome restoration, disruptor elimination, targeted supplementation with L-glutamine and zinc carnosine) rather than replacing them.
Q: Can probiotics make leaky gut worse?
A: In most contexts, appropriate probiotic use supports gut barrier integrity. Certain scenarios carry risk, though: administering probiotics containing live bacteria to severely immunocompromised individuals carries bacteremia risk; some probiotic strains may worsen SIBO if small intestinal bacterial overgrowth is already present; soil-based organisms (SBOs) can occasionally cause problems in people with severe dysbiosis. For most healthy adults with autoimmune conditions, well-researched probiotic strains (L. rhamnosus GG, L. plantarum 299v, B. longum) are safe and beneficial. Getting a comprehensive stool analysis before choosing probiotic strains allows a more targeted approach.
The key conclusion
Sandra’s story has a reasonably good ending. She eventually found a functional medicine practitioner who looked at her gut first: comprehensive stool analysis showed significant dysbiosis with low Akkermansia and Faecalibacterium prausnitzii, elevated H. pylori load, very low secretory IgA, and calprotectin suggesting intestinal inflammation. Serum zonulin was elevated. She’d never been tested for anti-gliadin antibodies, which came back positive on non-celiac sensitivity testing. The entire picture told a coherent story that her previous practitioners had missed, because each of them was looking only at their own specialty’s piece.
She completed a structured 5R gut restoration protocol. Eliminated gluten and dietary emulsifiers. H. pylori was treated with a functional medicine herbal protocol. She added L-glutamine, zinc carnosine, butyrate, and Akkermansia-supporting polyphenols. She prioritized sleep and started a twice-weekly yoga practice specifically for vagal tone and stress modulation. Within six months, her TPO antibodies had dropped by 40%. The psoriasis cleared significantly. The food sensitivity list stopped expanding for the first time in three years. She’s not cured — Hashimoto’s doesn’t simply disappear — but the disease is no longer progressing, and her quality of life is markedly better.
The Autoimmune Gut Assessment is not a replacement for appropriate medical management. It’s a framework for ensuring the gut — the probable origin point of the immune dysregulation driving most autoimmune conditions — gets the attention the research now clearly justifies. Treating autoimmunity without addressing intestinal permeability is like trying to fix a flooded basement by mopping the floor while the window stays broken. The water keeps coming in. The Fasano Triad gives you a map. Most people with autoimmune conditions have never been shown it. Now it’s in front of you. Start with the gut.
The intersection of genetics, environmental triggers, and intestinal permeability creates the autoimmune disease that medical science has historically treated as an inevitable, irreversible condition. The Fasano model offers a different framing: if three factors must all be present simultaneously, then addressing even one of those factors meaningfully — and the gut barrier is the most modifiable of the three — changes the disease trajectory. That’s not alternative medicine. That’s applied immunology. And it’s where the most promising research in autoimmunity is currently pointing.
The Practical Framework: Applying Leaky Gut Autoimmunity Connection In Real Life
References
Editorial StandardsCorrectionsMedical DisclaimerAbout Our ContentAffiliate DisclosureSite Map